Epigral consolidated net profit declines 37.00% in the September 2025 quarter
Sales decline 6.18% to Rs 587.36 crore
Net profit of Epigral declined 37.00% to Rs 51.22 crore in the quarter ended September 2025 as against Rs 81.30 crore during the previous quarter ended September 2024. Sales declined 6.18% to Rs 587.36 crore in the quarter ended September 2025 as against Rs 626.06 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales587.36626.06 -6 OPM %22.4828.50 -PBDT111.96157.43 -29 PBT69.65125.18 -44 NP51.2281.30 -37Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 10 2025 | 4:17 PM IST